PetMed Express, Inc.

Symbol: PETS

NASDAQ

4.83

USD

Market price today

  • -10.8113

    P/E Ratio

  • -0.1963

    PEG Ratio

  • 102.14M

    MRK Cap

  • 0.14%

    DIV Yield

PetMed Express, Inc. (PETS) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.28%

Operating Profit Margin

-0.04%

Net Profit Margin

-0.03%

Return on Assets

-0.05%

Return on Equity

-0.07%

Return on Capital Employed

-0.12%

Company general description and statistics

Sector: Healthcare
Industry: Pharmaceutical Retailers
CEO:Mr. Mathew N. Hulett
Full-time employees:302
City:Delray Beach
Address:420 South Congress Avenue
IPO:1999-04-26
CIK:0001040130

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

General Outlook

When we look at how much money they make before expenses, they keep 0.278% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.043%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.029%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.047% return, is a testament to PetMed Express, Inc.'s adeptness in optimizing resource deployment. PetMed Express, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.071%. Furthermore, the proficiency of PetMed Express, Inc. in capital utilization is underscored by a remarkable -0.118% return on capital employed.

Stock Prices

PetMed Express, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $4.12, while its low point bottomed out at $3.92. This variance in figures offers investors a lucid insight into the roller-coaster ride that is PetMed Express, Inc.'s stock market.

Liquidity Ratios

Analyzing PETS liquidity ratios reveals its financial health of the firm. The current ratio of 131.97% gauges short-term asset coverage for liabilities. The quick ratio (70.95%) assesses immediate liquidity, while the cash ratio (68.29%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio131.97%
Quick Ratio70.95%
Cash Ratio68.29%

Profitability Ratios

PETS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -3.36% underscores its earnings before tax deductions. The effective tax rate stands at 12.99%, revealing its tax efficiency. The net income per EBT, 87.01%, and the EBT per EBIT, 77.73%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -4.32%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-3.36%
Effective Tax Rate12.99%
Net Income per EBT87.01%
EBT per EBIT77.73%
EBIT per Revenue-4.32%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.32, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 14350.62% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding71
Days of Inventory Outstanding63
Operating Cycle65.62
Days of Payables Outstanding71
Cash Conversion Cycle-5
Receivables Turnover143.51
Payables Turnover5.15
Inventory Turnover5.79
Fixed Asset Turnover9.74
Asset Turnover1.60

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.34, and free cash flow per share, 0.08, depict cash generation on a per-share basis. The cash per share value, 2.42, showcases liquidity position. A payout ratio of -2.29 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.02, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.34
Free Cash Flow per Share0.08
Cash per Share2.42
Payout Ratio-2.29
Operating Cash Flow Sales Ratio0.02
Free Cash Flow to Operating Cash Flow Ratio0.25
Cash Flow Coverage Ratio4.21
Short Term Coverage Ratio9.20
Capital Expenditure Coverage Ratio1.33
Dividend Paid and Capex Coverage Ratio0.29
Dividend Payout Ratio0.07

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 0.95%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.02, we discern the balance between debt and equity financing. The long-term debt to capitalization, 0.88%, and total debt to capitalization, 1.61%, ratios shed light on its capital structure. An interest coverage of 11.04 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio0.95%
Debt Equity Ratio0.02
Long Term Debt to Capitalization0.88%
Total Debt to Capitalization1.61%
Interest Coverage11.04
Cash Flow to Debt Ratio4.21
Company Equity Multiplier1.73

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 12.67, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.01, reflects the portion of profit attributed to each share. The book value per share, 6.11, represents the net asset value distributed per share, while the tangible book value per share, 5.82, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share12.67
Net Income Per Share0.01
Book Value Per Share6.11
Tangible Book Value Per Share5.82
Shareholders Equity Per Share6.11
Interest Debt Per Share-0.15
Capex Per Share-0.26

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -6.06%, indicates top-line expansion, while the gross profit growth, -9.05%, reveals profitability trends. EBIT growth, -105.56%, and operating income growth, -105.56%, offer insights into operational profitability progression. The net income growth, -98.90%, showcases bottom-line expansion, and the EPS growth, -98.90%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-6.06%
Gross Profit Growth-9.05%
EBIT Growth-105.56%
Operating Income Growth-105.56%
Net Income Growth-98.90%
EPS Growth-98.90%
EPS Diluted Growth-98.89%
Weighted Average Shares Growth0.49%
Weighted Average Shares Diluted Growth-0.09%
Dividends per Share Growth0.14%
Operating Cash Flow Growth50.30%
Free Cash Flow Growth34.62%
10-Year Revenue Growth per Share10.80%
5-Year Revenue Growth per Share-5.86%
3-Year Revenue Growth per Share-10.64%
10-Year Operating CF Growth per Share105.60%
5-Year Operating CF Growth per Share-25.36%
3-Year Operating CF Growth per Share-29.25%
10-Year Net Income Growth per Share-98.67%
5-Year Net Income Growth per Share-99.37%
3-Year Net Income Growth per Share-99.11%
10-Year Shareholders Equity Growth per Share90.06%
5-Year Shareholders Equity Growth per Share7.34%
3-Year Shareholders Equity Growth per Share-5.88%
10-Year Dividend per Share Growth per Share-24.58%
5-Year Dividend per Share Growth per Share40.94%
3-Year Dividend per Share Growth per Share11.24%
Receivables Growth-9.04%
Inventory Growth-41.39%
Asset Growth-6.92%
Book Value per Share Growth-13.36%
SGA Expenses Growth38.83%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 225,180,000, captures the company's total value, considering both debt and equity. Income quality, 119.33, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 3.57%, indicates the value of non-physical assets, and capex to operating cash flow, -18.92%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value225,180,000
Income Quality119.33
Sales General and Administrative to Revenue0.19
Intangibles to Total Assets3.57%
Capex to Operating Cash Flow-18.92%
Capex to Revenue-2.05%
Capex to Depreciation-148.34%
Stock-Based Compensation to Revenue2.58%
Graham Number1.26
Return on Tangible Assets0.15%
Graham Net Net3.68
Working Capital94,954,000
Tangible Asset Value117,935,000
Net Current Asset Value91,129,000
Average Receivables1,826,500
Average Payables26,354,000
Average Inventory25,739,000
Days Sales Outstanding2
Days Payables Outstanding50
Days of Inventory On Hand37
ROIC-0.17%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.87, and the price to book ratio, 0.87, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.33, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 52.50, and price to operating cash flows, 12.64, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.87
Price to Book Ratio0.87
Price to Sales Ratio0.33
Price Cash Flow Ratio12.64
Price Earnings to Growth Ratio-0.20
Enterprise Value Multiple-23.85
Price Fair Value0.87
Price to Operating Cash Flow Ratio12.64
Price to Free Cash Flows Ratio52.50
Price to Tangible Book Ratio2.66
Enterprise Value to Sales0.88
Enterprise Value Over EBITDA106.42
EV to Operating Cash Flow8.10
Earnings Yield0.07%
Free Cash Flow Yield6.85%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of PetMed Express, Inc. (PETS) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -10.811 in 2024.

What is the ticker symbol of PetMed Express, Inc. stock?

The ticker symbol of PetMed Express, Inc. stock is PETS.

What is company IPO date?

IPO date of PetMed Express, Inc. is 1999-04-26.

What is company current share price?

Current share price is 4.830 USD.

What is stock market cap today?

The market cap of stock today is 102140010.000.

What is PEG ratio in 2024?

The current -0.196 is -0.196 in 2024.

What is the number of employees in 2024?

In 2024 the company has 302.